Elderly with proximal hip fracture present significantly lower levels of 25-hydroxyvitamin D  by Guerra, Marcelo Teodoro Ezequiel et al.
SO
E
s
M
J
a
b
a
A
R
A
A
K
V
H
O
C
h
2
ar e v b r a s o r t o p . 2 0 1 6;5 1(5):583–588
OCIEDADE  BRASILEIRA  DE
ORTOPEDIA E TRAUMATOLOGIA
www.rbo.org .br
riginal Article
lderly  with  proximal  hip  fracture  present
igniﬁcantly lower  levels  of 25-hydroxyvitamin  D
arcelo Teodoro Ezequiel Guerraa,b,∗, Eduardo Terra Feronb, Roberto Deves Vianab,
onathan  Mabonib, Stéfany Ignêz Pastoreb, Cyntia Cordeiro de Castrob
Universidade Luterana do Brasil (Ulbra), Departamento de Ortopedia e Traumatologia, Canoas, RS, Brazil
Universidade Luterana do Brasil (Ulbra), Hospital Universitário Mãe  de Deus, Servic¸o de Ortopedia e Traumatologia, Canoas, RS, Brazil
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 14 January 2016
ccepted 15 February 2016
vailable online 31 August 2016
eywords:
itamin D deﬁciency
ip fractures
steoporotic fractures
a  b  s  t  r  a  c  t
Objective: To compare serum 25-hydroxyvitamin D (25[OH]D) levels, a serum marker of vita-
min  D3, between patients with and without proximal hip fracture.
Methods: This was a case–control study in which serum samples of 25(OH)D were obtained
from 110 proximal hip fracture inpatients and 231 control patients without fractures, all
over  60 years of age. Levels of 25(OH)D lower than or equal to 20 ng/mL were considered
deﬁcient; from 21 ng/mL to 29 ng/mL, insufﬁcient; and above 30 ng/mL, sufﬁcient. Sex, age,
and  ethnicity were considered for association with the study groups and 25(OH)D levels.
Results: Patients with proximal hip fracture had signiﬁcantly lower serum 25(OH)D levels
(21.07 ng/mL) than controls (28.59 ng/mL; p = 0.000). Among patients with proximal hip frac-
ture,  54.5% had deﬁcient 25(OH)D levels, 27.2% had insufﬁcient levels, and only 18.2% had
sufﬁcient levels. In the control group, 30.3% of patients had deﬁcient 25(OH)D levels, 30.7%
had insufﬁcient levels, and 38.9% had sufﬁcient levels. Female patients had decreased
serum 25(OH)D levels both in the fracture group and in the control group (19.50 ng/mL
vs.  26.94 ng/mL; p = 0.000) when compared with male patients with and without fracture
(25.67 ng/mL vs. 33.74 ng/mL; p = 0.017). Regarding age, there was a signiﬁcant association
between 25(OH)D levels and risk of fracture only for the age groups 71–75 years and above
80  years.
Conclusion: Patients with proximal hip fracture had signiﬁcantly decreased serum 25(OH)D
levels when compared with the control group. Female patients had signiﬁcantly lower serum
25(OH)D levels in both groups.© 2016 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Ortopedia
e  Traumatologia. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/). Study conducted at the Universidade Luterana do Brasil (Ulbra), Hospital Universitário, Departamento de Ortopedia e Traumatologia,
anoas, RS, Brazil.
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Idosos  com  fratura  da  extremidade  proximal  do  fêmur  apresentam  níveis
signiﬁcativamente  menores  de  25-hidroxivitamina  D
Palavras-chave:
Deﬁciência de vitamina D
Fraturas do quadril
Fraturas por osteoporose
r  e  s  u  m  o
Objetivo: Comparar os níveis séricos de 25-hidroxivitamina D [25(OH)D], marcador sérico da
vitamina D3, entre pacientes com e sem fratura da extremidade proximal do fêmur (FEPF).
Métodos: Estudo caso-controle em que foram obtidas amostras séricas de 25(OH)D de 110
pacientes com FEPF internados e de 231 pacientes de grupo controle que não apresentaram
fraturas, todos acima de 60 anos. Níveis de 25(OH)D menores ou iguais a 20 ng/mL foram
considerados deﬁcitários; entre 21 ng/mL e 29 ng/mL, insuﬁcientes; e acima de 30 ng/mL,
suﬁcientes. Foram consideradas as variáveis sexo, idade e etnia para associac¸ão com os
grupos em estudo e os níveis de 25(OH)D.
Resultados: Pacientes com FEPF apresentaram níveis séricos de 25(OH)D signiﬁcativamente
inferiores (21,07 ng/mL) comparados com os do grupo controle (28,59 ng/mL; p = 0,000). Entre
os  pacientes com FEPF, 54,5% apresentaram níveis de 25(OH)D deﬁcitários, 27,2% insuﬁ-
cientes e apenas 18,2% suﬁcientes. Já no grupo controle, 30,3% dos pacientes apresentaram
níveis deﬁcitários, 30,7% insuﬁcientes e 38,9% suﬁcientes. Pacientes do sexo feminino apre-
sentaram níveis séricos de 25(OH)D reduzidos tanto no grupo com fratura quanto no grupo
controle (19,50 vs.  26,94 ng/mL; p = 0,000) comparados com os do sexo masculino com e sem
fratura (25,67 vs.  33,74 ng/mL; p = 0,017). Quanto à idade, houve associac¸ão signiﬁcativa entre
os  níveis de 25(OH)D e risco de fratura apenas para as faixas 71-75 anos e acima de 80.
Conclusão: Pacientes com FEPF apresentaram níveis séricos de 25(OH)D signiﬁcativamente
reduzidos em comparac¸ão com os do grupo controle. Pacientes do sexo feminino apresen-
taram níveis séricos de 25(OH)D signiﬁcativamente menores em ambos os grupos.
© 2016 Publicado por Elsevier Editora Ltda. em nome de Sociedade Brasileira de
Ortopedia e Traumatologia. Este e´ um artigo Open Access sob uma licenc¸a CC BY-NC-NDIntroduction
Proximal femoral fracture (PFF) has a high incidence in
patients older than 65 years and usually results from low-
energy trauma. Despite the resources of modern medicine,
there is a high mortality rate, around 25–30% yearly.1–3
Mortality is mainly due to factors such as advanced age,
comorbidities, previous cognitive impairment, and delay in
the procedure.1,2 PFF also represents a major cost to public
health, mainly due to prolonged hospitalization and related
surgical procedures.3,4
Vitamin D plays an important role in calcium metabolism,
and consequently in bone mineralization and the osteoporotic
picture. Its deﬁciency is therefore an important risk factor for
PFF in the elderly.1,5,6 The best serum marker of this vitamin
is 25-hydroxyvitamin D (25(OH)D), whose metabolic product is
vitamin D3; values equal to or above 30 ng/mL are considered
sufﬁcient.7 The use of vitamin D3 has been recommended to
prevent fractures in elderly patients with osteoporosis. How-
ever, it is not always routinely used in public healthcare.8–10
This study aimed to compare serum 25(OH)D levels among
elderly patients with and without PFF, and to analyze the asso-
ciation of variables such as gender, age, and ethnicity with this
condition.
Material  and  methodsThis was a case–control study conducted in the Depart-
ment of Orthopedics and Traumatology of this institution(http://creativecommons.org/licenses/by-nc-nd/4.0/).
between January 2013 and May 2015. The study was approved
by the Ethics Committee of the institution under CAAE No.
33760914.8.0000.5349.
The fracture group comprised patients over 60 years
with PFF. The study included patients with femoral neck,
subtrochanteric, and transtrochanteric fractures who  had
experienced a low-energy fall. The control group included age-
matched individuals without PFF history, recruited among the
patients attended to at the orthopedics clinic and other med-
ical specialties at this hospital, as well as inpatients admitted
for non-orthopedic/traumatological reasons. The exclusion
criteria comprised patients outside the age range; with frac-
tures with known history of high energy; with missing data on
medical records, such as ethnicity and sex; or with unknown
serum levels or without results provided by the laboratory.
Serum 25(OH)D samples were collected for all patients.
In the fracture group, blood samples were collected immedi-
ately after the patient’s admission, before the ﬁnal surgical
procedure. In the control group, samples were collected after
outpatient care. Serum levels were measured in a standard
laboratory for all samples, measured as nanograms per
milliliter (ng/mL).
The results of the blood collection of 25(OH)D were divided
in accordance with the Horlick classiﬁcation, where values
below 20 ng/mL are considered deﬁcient; between 21 and
29 ng/mL, insufﬁcient; and above 30 ng/mL, normal.7 The vari-
ables gender, age, and ethnicity were considered for purposes
of association with the study groups and levels of 25(OH)D.
In order to reject the null hypothesis that serum 25(OH)D
would be equal in the case and control groups, the minimum
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Table 1 – Sample characterization.
Variable Group p
Control (n = 231) Fracture (n = 110) Total (n = 341)
n % n % n %
Ethnicity
White 218 94.4 106 96.4 324 95.0 0.839a
Black 9 3.9 3  2.7 12 3.5
Mixed 4 1.7 1  0.9 5 1.5
Sex
Female 175 75.8 82 74.5 257 75.4 0.808b
Male 56 24.2 28 25.5 84 24.6
Age (years)
60–65 24 10.4 12 10.9 36 10.6 0.850b
66–70 16 6.9 8 7.3 24 7.0
71–75 50 21.6 21 19.1 71 20.8
76–80 51 22.1 20 18.2 71 20.8
>80 90 39.0 49 44.5 139 40.8
Source: Authors
a Chi-squared test.
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males, the mean was signiﬁcantly higher in the control group
(33.74 ± 14.08 ng/mL) when compared with the fracture group
(25.67 ± 9.85 ng/mL, p = 0.017).
Table 2 – Serum levels of 25(OH)D in the fracture and
control groups according to the Horlick classiﬁcation.
25(OH)D Control Fracture Total
n % n % n %
Deﬁcient 70 30.3 60 54.5 130 38.1
Insufﬁcient 71 30.7 30 27.2 101 29.6
Sufﬁcient 90 38.9 20 18.2 110 32.2Fisher’s exact test.
ample size calculated to obtain statistically signiﬁcant results
as 60 patients with PFF (fracture group) and 120 patients
ithout PFF (control group).
tatistical  analysis
he statistical program used was SPSS, version 13.0. Results
ere considered signiﬁcant at a level of 5% (p ≤ 0.05). Data
ere expressed as mean and standard deviation or per-
entage (%). The statistical difference between the fracture
nd control groups and their respective variables was cal-
ulated with the chi-squared and Fisher’s exact tests. The
olmogorov–Smirnov test of normality indicated that the
tudy variables did not present normal distribution; there-
ore, a nonparametric test was used in the analysis. The
ann–Whitney test was used to compare the mean serum
evels of 25(OH)D between groups, and these values were strat-
ﬁed by age and gender. For the ethnicity variable, it was not
ossible to perform statistical tests due to the insufﬁcient
umber of cases for the mixed and black ethnicities.
esults
he present sample comprised 341 patients. The fracture
roup included 110 patients, of whom 82 (74.5%) were female,
nd the control group consisted of 231 patients, of whom
75 (75.8%) were female. Mean age of the fracture patients
as 78.76 ± 9.52 years, and mean age of the controls was
7.31 ± 7.85 years. There was no difference between groups
egarding sex or age (p > 0.05). Sample characteristics are
escribed in Table 1.The serum levels of 25(OH)D in the control group
28.59 ± 12.31 ng/mL) were signiﬁcantly higher than in the
racture group (21.07 ± 10.28 ng/mL) (p = 0.000). In the fracture
roup, considering the Horlick classiﬁcation, 54.5% (n = 60)patients had deﬁcient serum 25(OH)D levels, and only 18.2%
(n = 20) had sufﬁcient values. Among the controls, 38.9% (n = 90)
were considered to have sufﬁcient serum levels; 30.3% had
deﬁcient serum levels (n = 70) (Table 2).
There were no signiﬁcant differences between the groups
regarding the serum levels of 25(OH)D for the age ranges of
60–65 years (p = 0.327), 66–70 (p = 0.417), and 76–80 (p = 0.095).
However, signiﬁcant differences were observed in the age
groups 71–75 years (p = 0.003) and over 80 (p = 0.003) (Table 3).
For the ethnicity variable, statistical analysis was not pos-
sible due to insufﬁcient number of cases for the mixed and
black ethnicities. Descriptive data for this variable are shown
in Table 4.
Regarding gender, a signiﬁcant difference was observed
in the levels of 25(OH)D between the groups. Lower serum
25(OH)D levels were observed in female patients, with
a mean of 19.50 ± 10.01 ng/mL in the fracture group and
26.94 ± 11.23 ng/mL in the control group (p = 0.000). AmongTotal 231 100.0 110 100.0 341 100.0
Source: Authors
25 (OH) D, 25-hydroxyvitamin D.
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Table 3 – Comparison of serum 25(OH)D between the
fracture and control groups according to age group.
Age Group n Mean SD pa
60–65
years
Control 24 31.5 11.52 0.327
Fracture 12 24.1 14.38
66–70
years
Control 16 32.22 10.58 0.417
Fracture 8 29.19 11.79
71–75
years
Control 50 28.43 11.37 0.3
Fracture 21 20.50 8.33
76–80
years
Control 51 30.82 9.96 0.95
Fracture 20 25.83 9.61
>80
years
Control 90 26.11 14.8 0.3
Fracture 49 17.34 8.37
Source: Authors
SD, standard deviation.
a p = 0.01.
Table 4 – Comparison of serum levels of 25(OH)D
between the fracture and control groups according to
ethnicity.
Ethnicity Control Fracture
n Mean SD n Mean SD
White 218 28.73 12.30 106 20.76 10.10
Mixed 9 23.38 10.77 3 29.59 16.32
Black 4 32.83 16.24 1 28.50 0.0
Source: Authors
England, reported that the use of vitamin D3 associated withSD, standard deviation.
Discussion
This study showed that patients with PFF had signiﬁcantly
lower serum 25(OH)D levels than the control group. Val-
ues considered insufﬁcient in the Horlick classiﬁcation were
observed in both the control group (28.59 ng/mL) and in the
fracture group (21.07 ng/mL). Considering this classiﬁcation,
half of patients with PFF had deﬁcient levels of this vitamin.
Low levels of 25(OH)D were also found in the control sam-
ple, with 30.7% of patients with insufﬁcient levels and 30.3%
deﬁcient.
In a meta-analysis that included 15 case–control studies
among patients with and without PFF, of the 17 patients ana-
lyzed, the serum levels of 25(OH)D in patients with fracture
were signiﬁcantly lower than in the control group.11 Rama-
son et al.12 conducted a study with 485 elderly with PFF and
also found low levels of 25(OH)D in these patients, with a
mean value of 19.1 ng/mL, 57.5% deﬁcient, 34.5% insufﬁcient,
and only 8% had sufﬁcient levels. Browne et al.,13 using a dif-
ferent serum measuring unit (nmol/L) in a study in Ireland
with 156 elderly patients with PFF, found that over 67% of
their sample had insufﬁcient or deﬁcient 25(OH)D serum lev-
els. Gumiero et al.,14 in a Brazilian study on gait in patients
with PFF, also observed low levels of 25(OH)D, with a mean
value of 27.8 ng/mL; 33.7% of the sample had deﬁcient val-
ues, which differs from the ﬁndings of the present study.7,14
Reduced serum levels of 25(OH)D were signiﬁcantly related
to PFF both in the present study and in previous studies;1 6;5 1(5):583–588
however, speciﬁc differences in serum levels of this vita-
min  are recognized by various authors, due to its relation
to sun exposure and the genetic characteristics of the local
population.11–13
Considering patients without PFF, Saraiva et al.15 also found
the presence of hypovitaminosis in a study in an elderly pop-
ulation, having subdivided the sample into two  groups. In
the ﬁrst group, consisting of hospitalized patients, 80% had
25(OH)D deﬁciency or insufﬁciency. In the second group, con-
sisting of outpatients, lower values – albeit still signiﬁcant
– were observed: around 55% insufﬁciency or deﬁciency in
serum levels, which are similar to those found in the control
group of the present study.
Females had signiﬁcantly lower levels of 25(OH)D in both
groups of the present study, demonstrating the predomi-
nance of this hypovitaminosis in women, a feature recognized
by many  authors. In a review study, Patton et al. reported
that 25(OH)D levels were comparatively lower in women,
regardless of the cut-off criteria used.6,13–18 Labronici et al.,18
when assessing post-menopausal women, found that 82%
of the patients had 25(OH)D levels considered insufﬁcient.
Several studies have reported a gradual decline of this vita-
min’s levels after menopause, which is more  signiﬁcant in
older patients. Cauley et al.,19 in a study of over 90,000 post-
menopausal women, observed a prevalence of low levels of
25(OH)D among these patients, as well as the subsequent
increase in the risk associated with PFF, suggesting serum con-
trol in post-menopausal patients as method to investigate this
risk. 16,17,19–21
Despite the predominance in females, males from the frac-
ture group also presented serum levels considered insufﬁcient
(25.67 ng/mL) in the present study. In a prospective study of
1,608 elderly males, Cauley et al.22 demonstrated a signiﬁ-
cant increase in the risk of hip fractures in patients with low
levels of 25(OH)D. The risk of fracture was signiﬁcant only in
male patients with deﬁcient serum levels, which was associ-
ated with both PFF23 and bone mineral density of the proximal
femur.24
In the present study, the association between vitamin D
deﬁciency and the age variable was signiﬁcant only in patients
aged between 71 and 75 years (p = 0.003) and over 80 (p = 0.003).
Ensrud et al.,24 considering only the male population, found
a signiﬁcant association between bone loss and low levels
of 25(OH)D among those aged over 75 years. Some authors
consider that 25(OH)D levels could present an uneven dis-
tribution, characterized by a stable pattern after a certain
age.17–19 In the present study, a division according to age of the
patients was made in order to discriminate the risk in certain
age groups. However, no other studies with this methodology
were retrieved, hindering a proper comparison. The variable
ethnicity presented an insufﬁcient sample, a limitation also
found by many  authors in their analysis19,25 Nevertheless,
some authors consider that greater skin pigmentation due to
genetic factors may be related to lower serum levels of vitamin
D.12,19,25
Chapuy et al.,8 in a classic clinical trial conducted incalcium led to a signiﬁcant reduction in risk of fractures in
elderly women that did not involve the spine when compared
with a control group. Therefore, the prophylactic use of this
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itamin is recognized by many  authors as an important factor
n preventing fractures, especially PFF.1–4
The main strength of the present sample was its consider-
ble size of 341 patients. In the meta-analysis performed by Lai
t al.,11 of the 15 case–control studies with values of 25(OH)D
onsidered signiﬁcant in elderly PFF, only three showed a total
ample higher than that of the present study. Even with a good
ample, one bias of the present study was the non-seasonal
haracterization of the collection year, since sun exposure is
nown to be associated with levels of 25(OH)D, being relevant
ven in relation to the inadequate intake of this vitamin.11
he time of serum collection of 25(OH)D, which was made at
dmission by transfer from another institution and showed
ariations, may also be considered a limitation of the present
tudy. Furthermore, the study did not consider the clinical
nd metabolic situations presented by the patient who under-
ent the exam, such as changes in kidney or liver function,
ormonal changes in thyroid function, and medication use,
mong others. However, despite representing sources of bias,
uch situations could constitute confounding factors to the
arious types of variables to be considered.10,11
onclusion
ower levels of vitamin D3 were observed in elderly patients
ith PFF when compared with control patients without frac-
ure. Signiﬁcantly lower levels of this vitamin in female
atients were observed in both groups. There was a signiﬁcant
ssociation between the risk of this hypovitaminosis with PFF
n the age ranges between 71 and 75 years and above 80 years.
hese ﬁndings demonstrate the important role of vitamin D3
n the outcome of PFF; its widespread use is suggested as a
ay to prevent this condition.
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